BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2534016)

  • 1. [Prostacyclin (PGI2) biosynthetic activity in variously differentiated neoplasms and the surrounding tissue].
    Schulz S; Mentz P; Timmel H; Giessler C
    Zahn Mund Kieferheilkd Zentralbl; 1989; 77(8):811-4. PubMed ID: 2534016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostacyclin (PGI2) biosynthesis in oral squamous epithelium carcinoma and mouth mucosa in relation to clinical and histological findings].
    Schulz S; Mentz P; Timmel H; Giessler C
    Zahn Mund Kieferheilkd Zentralbl; 1986; 74(1):37-42. PubMed ID: 2938366
    [No Abstract]   [Full Text] [Related]  

  • 3. Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation.
    Brooks MD; Bennett RD; Strehler EE; Sebo TJ; Eckert SE; Carr AB
    J Prosthodont; 2009 Jan; 18(1):11-6. PubMed ID: 19166543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
    Hague A; Packham G; Huntley S; Shefford K; Eveson JW
    J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [S phase fraction and immunohistologic demonstration of the epithelial marker MAM-6 in orofacial tumors].
    Kunz J; Ruschin P; Zotter S
    Zentralbl Allg Pathol; 1986; 132(3):233-42. PubMed ID: 3788316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis.
    Kotelnikov VM; Coon JS; Mundle S; Kelanic S; LaFollette S; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Preisler HD
    Clin Cancer Res; 1997 Jan; 3(1):95-101. PubMed ID: 9815543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adducin expression in cutaneous and oral lesions: alpha- and beta-adducin transcripts down-regulate with keratinocyte differentiation in stratified epithelia.
    Bowen SL; Bloor BK; Leigh IM; Waseem A
    J Pathol; 2003 Sep; 201(1):119-26. PubMed ID: 12950024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintained CD40 and loss of polarised CD40 ligand expression in oral squamous cell carcinoma.
    Loro LL; Ohlsson M; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
    Anticancer Res; 2001; 21(1A):113-7. PubMed ID: 11299724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase-3 expression is reduced, in the absence of cleavage, in terminally differentiated normal oral epithelium but is increased in oral squamous cell carcinomas and correlates with tumour stage.
    Hague A; Eveson JW; MacFarlane M; Huntley S; Janghra N; Thavaraj S
    J Pathol; 2004 Oct; 204(2):175-82. PubMed ID: 15376256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ha-ras oncogene product in human oral squamous cell carcinoma.
    Oku N; Shimada K; Itoh H
    Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas.
    Landesberg R; Woo V; Huang L; Cozin M; Lu Y; Bailey C; Qu W; Pulse C; Schmidt AM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):617-24. PubMed ID: 18206396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chlorin p6 for photodynamic treatment of squamous cell carcinoma in the hamster cheek pouch model.
    Dube A; Sharma S; Gupta PK
    Oral Oncol; 2006 Jan; 42(1):77-82. PubMed ID: 16140565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative investigation of keratin-filaments in normal tissues and tumours of skin, oral mucosa, salivary glands and thymus.
    Löning T; Viac J; Caselitz J; Thivolet J; Otto HF; Seifert G
    Pathol Res Pract; 1982; 175(2-3):256-65. PubMed ID: 6190148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
    Hindermann W; Berndt A; Borsi L; Luo X; Hyckel P; Katenkamp D; Kosmehl H
    J Pathol; 1999 Dec; 189(4):475-80. PubMed ID: 10629546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MICA and MICB overexpression in oral squamous cell carcinoma.
    Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
    J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phosphotyrosine in squamous cell carcinoma of the oral mucosa. Preliminary study.
    Maiorano E; Favia G
    Boll Soc Ital Biol Sper; 1995; 71(5-6):157-62. PubMed ID: 8519490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.